published_or_final_version / Nursing Studies / Master / Master of Nursing

published_or_final_version / Nursing Studies / Master / Master of Nursing

Wan Pui Chu Christina. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 167-191). / Abstracts in English and Chinese. / PUBLICATIONS BASED ON WORK IN THIS THESIS --- p.i / ABSTRACT --- p.ii / ACKNOWLEDGEMENT --- p.vii / TABLE OF CONTENTS --- p.viii / Chapter CHAPTER 1 --- INTRODUCTION --- p.1 / Chapter 1.1 --- Introduction to the Vanilloid Receptor --- p.1 / Chapter 1.1.1 --- Properties of the VR1 Channel --- p.2 / Chapter 1.1.2 --- Explaining the Unexplained: De sensitization and Pungency --- p.6 / Chapter 1.2 --- The Quest for the Endogenous Ligand: Activation versus Modulation --- p.2 / Chapter 1.2.1 --- Anandamide and the Cannabinoid System --- p.12 / Chapter 1.2.2 --- Inflammatory Mediators and Lipid Metabolites --- p.15 / Chapter 1.3 --- The Variegated Vanilloid Receptor: Multiple Actions of TRPV1 --- p.18 / Chapter 1.3.1 --- Vanilloid-induced Hypothermia: some like it cold --- p.18 / Chapter 1.3.2 --- "Three's a crowd: Vanilloids, Substance P, and the Emetic Reflex" --- p.22 / Chapter 1.3.3 --- Grooming Behavior and Locomotor Changes: Further Involvement of Neurokinins? --- p.29 / Chapter 1.4 --- Aims and Objectives of the Present Study --- p.33 / Chapter CHAPTER 2 --- METHODS --- p.39 / Chapter 2.1 --- Animals --- p.39 / Chapter 2.2 --- Stereotaxic Surgery and Transmitter Implantation --- p.39 / Chapter 2.3 --- Measurement of Emesis and Genital Grooming --- p.41 / Chapter 2.4 --- Measurement of Locomotor Activity and Body Temperature --- p.41 / Chapter 2.5 --- Experimental Procedures for Central Injection Studies --- p.45 / Chapter 2.6 --- Experimental Procedures for Peripheral Injection Studies --- p.47 / Chapter 2.7 --- Drug Formulation --- p.48 / Chapter 2.8 --- Statistical Analysis --- p.49 / Chapter CHAPTER 3 --- RESULTS --- p.51 / Chapter 3.1 --- Actions of Intracerebroventricularly Administered Vanilloid Agonists --- p.51 / Chapter 3.1.1 --- General Behaviour --- p.51 / Chapter 3.1.2 --- Emetic Action of Vanilloids --- p.52 / Chapter 3.1.3 --- Anti-Emetic action of Vanilloids against Copper Sulphate --- p.55 / Chapter 3.1.4 --- Vanilloid-induced Hypothermia --- p.58 / Chapter 3.1.5 --- RTX-induced Genital Grooming --- p.65 / Chapter 3.1.6 --- Effects of Vanilloids on Locomotor Activity --- p.67 / Chapter 3.1.7 --- Summary of Central Agonist Studies --- p.76 / Chapter 3.2 --- Effects of Intracerebroventricularly Administered Capsazepine on Vanilloid-induced Responses --- p.78 / Chapter 3.2.1 --- Effect of Capsazepine on Vanilloid-induced Emesis --- p.78 / Chapter 3.2.2 --- Effect of Capsazepine on the Anti-Emetic Action of Vanilloids --- p.82 / Chapter 3.2.3 --- Effect of Capsazepine on Vanilloid-induced Hypothermia --- p.84 / Chapter 3.2.4 --- Effect of Capsazepine on RTX-induced Genital Grooming --- p.88 / Chapter 3.2.5 --- Effect of Capsazepine on Locomotor Activity of Vanilloid-treated Animals --- p.90 / Chapter 3.3 --- "Peripheral Studies with RTX，,Capsazepine, and Ruthenium Red" --- p.93 / Chapter 3.1.1 --- Experiment 1: Actions of Resiniferatoxin --- p.93 / Chapter 3.1.2 --- Experiment 2: Effects of Capsazepine and Ruthenium Red administered alone --- p.99 / Chapter 3.1.3 --- Experiment 3: Effects of Capsazepine and Ruthenium Red on RTX- induced Responses --- p.104 / Chapter CHAPTER 4 --- DISCUSSION --- p.113 / Chapter 4.1 --- General Considerations --- p.113 / Chapter 4.2 --- Emetic Action of Vanilloids --- p.116 / Chapter 4.3 --- Anti-Emetic Action of Vanilloids --- p.124 / Chapter 4.4 --- Hypothermic Action of Vanilloids --- p.133 / Chapter 4.5 --- Resiniferatoxin-induced Genital Grooming --- p.147 / Chapter 4.6 --- Actions of Capsazepine and Ruthenium Red --- p.152 / Chapter 4.7 --- Locomotor Activity --- p.157 / Chapter CHAPTER 5 --- SUMMARY --- p.162 / REFERENCES --- p.167

Lu, Zengbing. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 206-217). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Despite a rise in breast cancer incidence, mortality rates have fallen. This improvement in mortality is due to the success of anti-cancer treatments such as chemotherapy and radiotherapy. Such treatments, however, are known to be associated with a range of symptoms. A number of studies exploring patients’ chemotherapy-related symptom experiences have shown that patients consistently rate nausea and fatigue highly, not only in relation to severity, but also in relation to the associated distress they experience. The subjective and non-observable nature of both nausea and fatigue complicates their assessment. While a range of assessment tools exists to evaluate patients’ experiences of these two symptoms, there is currently no gold standard assessment tool for assessing either symptom. Moreover, while a range of pharmacological and non-pharmacological interventions have been developed for both symptoms, further evaluation is often needed to provide the level of evidence required to recommend their implementation in real life clinical environments. The SNA↔P (structured nursing assessment into practice) study arose in response to this clinical situation. The SNA↔P study was a longitudinal study that evaluated the impact of a complex evidence-based intervention, incorporating structured multidimensional symptom assessment and multiple symptom management techniques, on patients’ experiences of nausea and fatigue during a course of chemotherapy for breast cancer. Using complementary quantitative and qualitative research methods not only allowed in-depth understanding of patients’ experiences and patterns of nausea and fatigue during a course of chemotherapy, but also facilitated a rounded evaluation of the intervention, incorporating both statistical elements and those of personal significance. The use of these methods showed that the implementation of the SNA↔P intervention in routine clinical practice has significant potential for improving patients’ symptom experiences during a course of chemotherapy. In so doing, it also highlighted a number of areas in which clinical practice can be influenced, and research conducted, to further improve patients’ symptom experiences.